Saturday, May 14, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study finds SARS-CoV-2 infection caused significant changes in the levels of stress associated small RNAs

by Medical Finance
in Coronavirus
Study: SARS-CoV-2 Causes a Significant Stress Response Mediated by Small RNAs in the Blood of COVID-19 Patient. Image Credit: creativeneko/Shutterstock
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

The coronavirus disease 2019 (COVID-19) pandemic has been caused by a highly infectious RNA virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This ongoing pandemic has immensely affected the global economy and healthcare system. SARS-CoV-2 symptoms could be mild, moderate, severe, or critical.


Study: SARS-CoV-2 Causes a Significant Stress Response Mediated by Small RNAs in the Blood of COVID-19 Patient. Image Credit: creativeneko/ShutterstockStudy: SARS-CoV-2 Causes a Significant Stress Response Mediated by Small RNAs in the Blood of COVID-19 Patient. Image Credit: creativeneko/Shutterstock


Background


Scientists have reported that approximately 28% of deaths occurred due to cytokine storms and sepsis induced by SARS-CoV-2 infection. Previous studies associated with molecular pathogenesis and pathophysiology of COVID-19 infection revealed the occurrence of renin-angiotensin-aldosterone system (RAAS) dysregulation, hyper inflammation, hypoxia, cytokine storm, thrombosis, and endotheliopathy.


Some individuals infected with SARS-CoV-2 have suffered dysfunctional hyperinflammatory responses with prolonged fevers and high levels of inflammatory marker. Severely infected COVID-19 patients revealed an elevated concentration of proinflammatory cytokines and chemokines. Another subset of severely infected COVID-19 patients suffered a dysfunctional hyperinflammatory response without fevers and multiple organ failure. A previous study reported considerable changes in C-reactive protein (CRP) levels in sera of critically ill COVID-19 patients.


Promising COVID-19 therapeutics using small molecules


Even though many studies have focused on the mechanisms of infection, COVID-19 pathogenesis, and disease processes are not well understood. Several studies have reported the role of microRNAs (miRNAs) in the process of virus infection. miRNAs are a type of small non-coding RNA (sncRNA) whose size varies between 18 and 22 nucleotides.


They damage the receptor genes, which assist virus entry to the host cell, by promoting degradation or translational inhibition of target transcripts by binding to the 3′ UTR (untranslated region). miRNAs have several other functions that include regulating virus replication or translation cofactors, affecting initial or adaptive immune genes, silencing genes, and promoting cell apoptosis. 


Previous studies have shown abnormal expression of miRNAs in viral diseases, such as enterovirus and chronic hepatitis. These reports have laid a foundation for the future clinical application of miRNAs. Recently, clinicians were suggested to treat COVID-19 infected patients with a ‘nose cocktail’ of miRNA. Besides miRNA, tRNA-derived small RNAs (tsRNAs) have been reported to be stable and functional small molecules produced by reprocessing the precursors or mature transcripts of tRNA. The levels of tsRNAs correlate to stress conditions, such as temperature, starvation, virus infection, and cancer. 


Recent studies have reported that tsRNAs can protect genomes by targeting primer-binding sites (PBSs) of endogenous retroviruses (ERVs) or human T cell leukemia virus type 1 (HTLV1). In somatic cells, the two most abundantly found small RNAs are miRNAs and tsRNAs, and both are related to virus infection and the immune response. There is a gap in research about the functions of these small RNAs post-SARS-CoV-2 infection. 


A new study


Recently, scientists have addressed the above-stated research gap and conducted high-throughput sequencing to identify the repertoire of small RNAs expressed in the blood of patients with moderate to severe COVID-19 infection. They compared the results with a control group that comprised healthy individuals. This study is forthcoming in Molecular Therapy: Nucleic Acid. In this study, researchers described the effect of significant changes of small RNAs in the post-transcriptional regulatory network.


The authors revealed that both miRNAs and tsRNAs are changed owing to stress response and downstream pathway changes (e.g., immunity and inflammation). This study reported that sncRNA-induced stress response is a common pathway in all cells and, thereby, the effect of these stress-related small RNAs would be experienced by most cell types.


However, scientists have studied the effect of small RNA on whole blood samples. In the future, the effect of small RNAs could be studied based on individual cell types. Additionally, the expression and function of small RNAs require further validation to determine their role and mechanism in the development of COVID-19 infection.


Main findings


Scientists reported that the expression profile of miRNAs could be used to differentiate among different groups of COVID-19 patients accurately. They further reported that miRNAs regulate 60% of all protein-coding genes at the post-transcriptional level. This implies that miRNAs play a crucial role in cell development, differentiation, and immune processes.


Interestingly, researchers found the presence of several HI-DOWN miRNAs in the blood of SARS-CoV-2 infected patients that have antiviral functions. For instance, miR-181 can bind to the receptor gene CD163, affecting virus entry. Additionally, miR-130 can regulate HCV cofactors and affect its viral replication. This study also reported that miR-29 is an antiviral factor produced by IL-21 in CD4 T cells.


The findings of this study are in line with previous studies that revealed miR-335 directly regulates the stress response. Researchers have also highlighted that miRNAs are enriched in the ER stress pathway. The authors believe that miRNA-target genes should regulate the specificity, timing, and severity of the cell response to SARS-CoV-2 infection stresses.


Conclusion


The current study revealed that the small RNAs detected in the blood of COVID-19 patients are predominantly produced by the human genome and not by the SARS-CoV-2 genome. The authors suggested that SARS-CoV-2 infection causes considerable changes in the stress level associated with small RNAs and their functions. This study provides a potential idea of developing a new COVID-19 therapeutic intervention by regulating small RNA levels or activities.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Estimating the risk of hospitalisation and death in England

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

by Medical Finance
May 14, 2022
0

A study conducted by the UK Health Security Agency has recently estimated the rate of hospitalization and death due to...

PromoCell’s New GMP Certification – EXCiPACT

New production method developed to freeze-dry COVID-19 vaccines

by Medical Finance
May 14, 2022
0

UMass Lowell scientists are developing a production method to freeze-dry COVID-19 vaccines activated by messenger-RNA so they can be transported...

Study: Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection. Image Credit: Kateryna Kon/Shutterstock

Waning antibody responses in SARS-CoV-2-infected children and adults over time

by Medical Finance
May 14, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers evaluated the duration of antibodies against severe acute respiratory...

Study: Omicron infection enhances Delta antibody immunity in vaccinated persons. Image Credit: NIAID

SARS-CoV-2 Omicron infection boosts Delta immunity in those who have been vaccinated

by Medical Finance
May 14, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant that was first identified in South Africa and Botswana in...

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

by Medical Finance
May 14, 2022
0

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the...

Scientists discover antibody that inhibits a broad range of sarbecoviruses

Some states still pushing ineffective covid antibody treatments

by Medical Finance
May 14, 2022
0

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to...

Next Post
Study: Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies. Image Credit: sasaton krungsee/Shutterstock

Analyzing milk produced after maternal COVID-19 diagnosis for the presence of SARS-CoV-2

Study: Potential Associations Between Microbiome and COVID-19. Image Credit: Rost9/Shutterstock

Microbial characteristics of COVID-19

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. Image Credit: myboys.me/Shutterstock
    Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England
  • Study: SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids. Image Credit: Eugene B-sov/Shutterstock
    Direct effect of SARS-CoV-2 on the kidney
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply